80 related articles for article (PubMed ID: 30478527)
21. Additive Effect of Zfhx3/Atbf1 and Pten Deletion on Mouse Prostatic Tumorigenesis.
Sun X; Xing C; Fu X; Li J; Zhang B; Frierson HF; Dong JT
J Genet Genomics; 2015 Jul; 42(7):373-82. PubMed ID: 26233892
[TBL] [Abstract][Full Text] [Related]
22. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
24. Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.
Shao J; Washington MK; Saxena R; Sheng H
Carcinogenesis; 2007 Dec; 28(12):2476-83. PubMed ID: 17693663
[TBL] [Abstract][Full Text] [Related]
25. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
[TBL] [Abstract][Full Text] [Related]
26. ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.
De la Houssaye G; Vieira V; Masson C; Beermann F; Dufier JL; Menasche M; Abitbol M
Mol Vis; 2008; 14():1912-28. PubMed ID: 18958307
[TBL] [Abstract][Full Text] [Related]
27. New insights into PTEN regulation mechanisms and its potential function in targeted therapies.
Zhang P; Chen JH; Guo XL
Biomed Pharmacother; 2012 Oct; 66(7):485-90. PubMed ID: 22902055
[TBL] [Abstract][Full Text] [Related]
28. Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse.
Teng Y; Sun AN; Pan XC; Yang G; Yang LL; Wang MR; Yang X
Cancer Res; 2006 Jul; 66(14):6972-81. PubMed ID: 16849541
[TBL] [Abstract][Full Text] [Related]
29. A new transgenic mouse model for conditional overexpression of the Polycomb Group protein EZH2.
Koppens MA; Tanger E; Nacerddine K; Westerman B; Song JY; van Lohuizen M
Transgenic Res; 2017 Apr; 26(2):187-196. PubMed ID: 27807665
[TBL] [Abstract][Full Text] [Related]
30. Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer.
Ullman D; Dorn D; Rais-Bahrami S; Gordetsky J
Urology; 2018 Mar; 113():59-70. PubMed ID: 29225123
[TBL] [Abstract][Full Text] [Related]
31. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
[TBL] [Abstract][Full Text] [Related]
32. Subtle variations in Pten dose determine cancer susceptibility.
Alimonti A; Carracedo A; Clohessy JG; Trotman LC; Nardella C; Egia A; Salmena L; Sampieri K; Haveman WJ; Brogi E; Richardson AL; Zhang J; Pandolfi PP
Nat Genet; 2010 May; 42(5):454-8. PubMed ID: 20400965
[TBL] [Abstract][Full Text] [Related]
33. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
34. Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways.
Shan SW; Fang L; Shatseva T; Rutnam ZJ; Yang X; Du W; Lu WY; Xuan JW; Deng Z; Yang BB
J Cell Sci; 2013 Mar; 126(Pt 6):1517-30. PubMed ID: 23418359
[TBL] [Abstract][Full Text] [Related]
35. The purification and action of tumor factor extracted from mouse and human neoplastic tissue.
BURTON L; FRIEDMAN F; KASSEL R; KAPLAN ML; ROTTINO A
Trans N Y Acad Sci; 1959 Jun; 21():700-7. PubMed ID: 13806336
[No Abstract] [Full Text] [Related]
36. Haploinsufficiency of the lysosomal sialidase NEU1 results in a model of pleomorphic rhabdomyosarcoma in mice.
Machado ER; van de Vlekkert D; Sheppard HS; Perry S; Downing SM; Laxton J; Ashmun R; Finkelstein DB; Neale GA; Hu H; Harwood FC; Koo SC; Grosveld GC; d'Azzo A
Commun Biol; 2022 Sep; 5(1):992. PubMed ID: 36127469
[TBL] [Abstract][Full Text] [Related]
37. ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes.
Pezzè L; Meškytė EM; Forcato M; Pontalti S; Badowska KA; Rizzotto D; Skvortsova II; Bicciato S; Ciribilli Y
Cell Death Dis; 2021 Jul; 12(8):742. PubMed ID: 34315857
[TBL] [Abstract][Full Text] [Related]
38. Integrated Analysis of the ETS Family in Melanoma Reveals a Regulatory Role of ETV7 in the Immune Microenvironment.
Qu H; Zhao H; Zhang X; Liu Y; Li F; Sun L; Song Z
Front Immunol; 2020; 11():612784. PubMed ID: 33424867
[TBL] [Abstract][Full Text] [Related]
39. An epigenetic screening determines BET proteins as targets to suppress self-renewal and tumorigenicity in canine mammary cancer cells.
Xavier PLP; Cordeiro YG; Alexandre PA; Pires PRL; Saranholi BH; Silva ER; Müller S; Fukumasu H
Sci Rep; 2019 Nov; 9(1):17363. PubMed ID: 31758045
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a transgenic mouse to model ETV7 expressing human tumors.
Numata M; Klein Geltink RI; Grosveld GC
Transgenic Res; 2019 Feb; 28(1):115-128. PubMed ID: 30478527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
